A randomised single-centre trial of inhaled liposomal cyclosporine for bronchiolitis obliterans syndrome post-lung transplantation

INTRODUCTION: No proven treatments exist for bronchiolitis obliterans syndrome (BOS) following lung transplantation. Inhaled liposomal cyclosporine (L-CsA) may prevent BOS progression. METHODS: A 48-week phase IIb randomised clinical trial was conducted in 21 lung transplant patients with BOS assign...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:ERJ Open Res
Päätekijät: Iacono, Aldo, Wijesinha, Marniker, Rajagopal, Keshava, Murdock, Natalia, Timofte, Irina, Griffith, Bartley, Terrin, Michael
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: European Respiratory Society 2019
Aiheet:
Original Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6819986/
https://ncbi.nlm.nih.gov/pubmed/31687370
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/23120541.00167-2019
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia